Resources

Type of publications
Regions
Diseases

5192 results found

2021 ∙ Uaprasert, N. Panrong, K. Rojnuckarin, P. Chiasakul, T.

Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2021 ∙ Waqar, U. Ahmed, S. Gardezi, S. M. H. A. Tahir, M. S. Abidin, Z. U. Hussain, A. Ali, N. Mahmood, S. F.

Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2021 ∙ Trauer, J. M. Kawai, A. Coussens, A. K. Datta, M. Williams, B. M. McBryde, E. S. Ragonnet, R.

Timing of Mycobacterium tuberculosis exposure explains variation in BCG effectiveness: a systematic review and meta-analysis

  • All age groups
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Chiu, N. C. Chi, H. Tu, Y. K. Huang, Y. N. Tai, Y. L. Weng, S. L. Chang, L. Huang, D. T. Huang, F. Y. Lin, C. Y.

To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Prandi, G. M. Cocchio, S. Fonzo, M. Furlan, P. Nicoletti, M. Baldo, V.

Towards the elimination of cervical cancer: HPV epidemiology, real-world experiences and the potential impact of the 9-valent HPV vaccine

  • Adolescents
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Zhang, Z. Suo, L. Pan, J. Zhao, D. Lu, L.

Two-dose varicella vaccine effectiveness in China: a meta-analysis and evidence quality assessment

  • Western Pacific
  • China
  • Children
  • Adolescents
  • Varicella
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Knight, H. Jia, R. Ayling, K. Bradbury, K. Baker, K. Chalder, T. Morling, J. R. Durrant, L. Avery, T. Ball, J. K. Barker, C. Bennett, R. McKeever, T. Vedhara, K.

Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention

  • All age groups
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Cadeddu, C. Castagna, C. Sapienza, M. Lanza, T. E. Messina, R. Chiavarini, M. Ricciardi, W. de Waure, C.

Understanding the determinants of vaccine hesitancy and vaccine confidence among adolescents: a systematic review

  • Adolescents
  • Adults
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Wang, Qiang Yang, Liuqing Jin, Hui Lin, Leesa

Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Kling, K. Harder, T. Younger, Z. Burchard, G. Schmidt-Chanasit, J. Wichmann, O.

Vaccination against Japanese encephalitis with IC51: Systematic review on immunogenicity, duration of protection and safety

  • All age groups
  • Japanese encephalitis
  • Tick-borne encephalitis
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...